Enoxaparin
Pulmonary Embolism
Medical University of Gdanskother_biologicalPhase 1/2Active
B
60/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 48/ 100
- Competitive Position
- 95/ 100
Competitive context
5 Active assets in the Pulmonary Embolism cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Apixaban Medical University of Gdansk | Phase 3 | BB |
Tranexamic Acid Albert Einstein College of Medicine | Phase 4 | BB |
FONDAPARINUX Johns Hopkins University | Phase 2 | BB |
HEPARIN Johns Hopkins University | Phase 4 | B |
PERFLUTREN Thunder Bay Regional Health Research Institute | Early Phase 1 | C |
View all 14 →
Same molecule, other indications
Enoxaparin is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →